Every year nearly 13 million people in the world are diagnosed with cancer. 7.6 million die from it, making it the leading cause of death in developed countries and the second leading cause of death in the developing world.
While cures for cancer are hard to come by, there are promising avenues for diagnosis. Cancer biomarkers are one of them; they are molecular aberrations found in the tumors that predict the aggressiveness of a disease or the response to a treatment. Unfortunately, too few patients are tested for biomarkers and too many with identified biomarkers are not referred to the right drug or the right trial.
Enter CancerDriver, a free repository of cancer biomarkers intended to improve access to biomarker information for patients, physicians, researchers, and pharmaceutical companies. CancerDriver contains a database of all known biomarkers in oncology. It can be found on the web and soon on iOS and Android mobile platforms.
We had a chance to speak with Jean-Emmanuel Bibault and Charles Ferté, Co-Founders of CancerDriver, to discuss this revolutionary site.
Posts
No comments:
Post a Comment